XWELL Inc XWEL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if XWEL is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $1.42
- Day Range
- $1.37–1.43
- 52-Week Range
- $1.26–7.00
- Bid/Ask
- $1.37 / $1.46
- Market Cap
- $5.73 Mil
- Volume/Avg
- 9,288 / 13,190
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.21
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.36%
Company Profile
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresCheck, XpresSpa, Treat, and HyperPointe. XpresSpa is an airport retailer of wellness services and related products. Treat is a travel health and wellness brand that offers in-airport spa and wellness medical services. XpresCheck provides Covid-19 screening and diagnostic testing in partnership with the CDC. HyperPointe is a digital healthcare and data analytics relationship company.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 483
- Website
- https://www.xwell.com
Valuation
|
Metric
|
XWEL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.33 |
Price/Sales | 0.21 |
Price/Cash Flow | — |
Price/Earnings
XWEL
Financial Strength
|
Metric
|
XWEL
|
|---|---|
Quick Ratio | 3.37 |
Current Ratio | 3.67 |
Interest Coverage | — |
Quick Ratio
XWEL
Profitability
|
Metric
|
XWEL
|
|---|---|
Return on Assets (Normalized) | −38.50% |
Return on Equity (Normalized) | −69.68% |
Return on Invested Capital (Normalized) | −44.19% |
Return on Assets
XWEL
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Sgjkhbrs | Bqcfy | $212.9 Bil | |
DHR
| Danaher Corp | Dnfdqxnw | Lcztxvk | $177.5 Bil | |
IQV
| IQVIA Holdings Inc | Qzlkkkwg | Vtzqsl | $42.6 Bil | |
A
| Agilent Technologies Inc | Gzyzwkggyg | Zmxy | $41.1 Bil | |
IDXX
| IDEXX Laboratories Inc | Mgqwzsqyf | Lwfpj | $40.8 Bil | |
MTD
| Mettler-Toledo International Inc | Fqnzbkytc | Ldlzlt | $26.6 Bil | |
ICLR
| Icon PLC | Mhbltcsg | Qkfzpx | $24.7 Bil | |
ILMN
| Illumina Inc | Gkgcmywk | Whbxy | $19.3 Bil | |
WAT
| Waters Corp | Kfbcgkkxbj | Rkbvg | $19.0 Bil | |
LH
| Laboratory Corp of America Holdings | Gnsrbcwrq | Qjtpslb | $17.1 Bil |